GlassScriptPhysician profile
Thomas D Jones
NPI 1518953033
$9,318.66
in general payments reported to CMS, 2019-2025
48 companies · $1,541 in 2025
The $1,541 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $956 · 2021: $1,585 · 2022: $1,148 · 2023: $1,621 · 2024: $1,609 · 2025: $1,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,764 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,763.52 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,386.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,133.92 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,067.01 | 2020-2025 | |
| Glaxosmithkline, LLC. | $714.60 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $571.66 | 2019-2025 | |
| Amgen INC. | $522.74 | 2020-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $503.66 | 2019-2025 | Jardiance |
| Pfizer INC. | $457.24 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $309.20 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Astellas Pharma US INC | $300.69 | 2019-2025 | Veozah |
| Allergan, INC. | $297.28 | 2019-2020 | |
| Exact Sciences Corporation | $226.05 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $220.67 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Eisai INC. | $145.09 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $136.16 | 2025 | Rexulti |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.